Zobrazeno 1 - 10
of 527
pro vyhledávání: '"Philip S Wells"'
Autor:
Daniël Duijzer, Maria A. de Winter, Marc Carrier, Alexander T. Cohen, John-Bjarne Hansen, Karin A.H. Kaasjager, Ajay K. Kakkar, Saskia Middeldorp, Henrik T. Sørensen, Frank L.J. Visseren, Philip S. Wells, Jannick A.N. Dorresteijn, Mathilde Nijkeuter
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102569- (2024)
Background: After 3 months of anticoagulation for venous thromboembolism (VTE), the decision needs to be made whether to stop anticoagulation or extend treatment indefinitely. The VTE-PREDICT calculator can be used to estimate individual risks of VTE
Externí odkaz:
https://doaj.org/article/762594d3a38a49cfa6a9cbbcee03a280
Autor:
Edward G Spilg, Hanna Kuk, Lesley Ananny, Kylie McNeill, Vicki LeBlanc, Brent A Bauer, Amit Sood, Philip S Wells
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267240 (2022)
ObjectiveThe Stress Management and Resilience Training (SMART) program is an evidence-based intervention designed to build resilience in physicians in clinical practice. The objective of the current study was to assess the impact of the SMART program
Externí odkaz:
https://doaj.org/article/fd8fffd1caee482f8180491699017547
Autor:
Geert-Jan Geersing, Toshihiko Takada, Frederikus A Klok, Harry R Büller, D Mark Courtney, Yonathan Freund, Javier Galipienzo, Gregoire Le Gal, Waleed Ghanima, Jeffrey A Kline, Menno V Huisman, Karel G M Moons, Arnaud Perrier, Sameer Parpia, Helia Robert-Ebadi, Marc Righini, Pierre-Marie Roy, Maarten van Smeden, Milou A M Stals, Philip S Wells, Kerstin de Wit, Noémie Kraaijpoel, Nick van Es
Publikováno v:
PLoS Medicine, Vol 19, Iss 1, p e1003905 (2022)
BackgroundThe challenging clinical dilemma of detecting pulmonary embolism (PE) in suspected patients is encountered in a variety of healthcare settings. We hypothesized that the optimal diagnostic approach to detect these patients in terms of safety
Externí odkaz:
https://doaj.org/article/957272a8001d408f9fa1a47efe2fbaf0
Autor:
Lucia Caiano, Michael J. Kovacs, Alejandro Lazo-Langner, David R. Anderson, Susan R. Kahn, Vinay Shah, Scott Kaatz, Russell S. Zide, Sam Schulman, Isabelle Chagnon, Ranjeeta Mallick, Marc A. Rodger, Philip S. Wells
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:553-558
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2123736ba15c4d9c106084854d722804
https://doi.org/10.1016/j.jtha.2022.12.021
https://doi.org/10.1016/j.jtha.2022.12.021
Publikováno v:
ESMO Open, Vol 5, Iss 6 (2020)
Patients with cancer are at high risk of venous thromboembolic events, and this risk can be further increased in patients with certain cancer types and by cancer treatments. Guidelines on the prevention of cancer-associated thrombosis (CAT) recommend
Externí odkaz:
https://doaj.org/article/0a35c92834904a22a0cca08f69baf270
Autor:
Philip S. Wells, Isabel Theberge, Joshua Bowdridge, Erin Kelly, Ania Kielar, Melissa A Forgie, Susan John, Carl van Walraven
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 24 (2020)
Background Previous studies regarding survival in patients with splanchnic vein thrombosis (SVT) are limited. This study measured overall survival in a large cohort of SVTs through linkage to population‐based data. Methods and Results Using a previ
Externí odkaz:
https://doaj.org/article/53beb183b4b4483b972b3aba5f813749
Autor:
Maddie S. Stephen, Lana Castellucci, Marc Carrier, Lisa Duffett, Gregoire Le Gal, Marc Rodger, Philip S. Wells, Aurélien Delluc
Publikováno v:
Haematologica, Vol 105, Iss 6 (2020)
Externí odkaz:
https://doaj.org/article/eaf38a34b80f4bfc9c1fe5a2e5fb13ba
Autor:
Aurélien Delluc, Sébastien Miranda, Paul den Exter, Martha Louzada, Adriano Alatri, Shin Ahn, Manuel Monreal, Alok Khorana, Menno V. Huisman, Philip S. Wells, Marc Carrier
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
In patients with cancer-associated venous thromboembolism, knowledge of the estimated rate of recurrent events is important for clinical decision-making regarding anticoagulant therapy. The Ottawa score is a clinical prediction rule designed for this
Externí odkaz:
https://doaj.org/article/c7cbdfd72d35403da99aff096a1d46b5
Autor:
Vignan Yogendrakumar, Ronda Lun, Faizan Khan, Kristin Salottolo, Karine Lacut, Catriona Graham, Martin Dennis, Brian Hutton, Philip S Wells, Dean Fergusson, Dar Dowlatshahi
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234957 (2020)
IntroductionTo summarize and compare the effectiveness of pharmacological thromboprophylaxis to pneumatic compression devices (PCD) for the prevention of venous thromboembolism in patients with acute intracerebral hemorrhage.MethodsMEDLINE, PUBMED, E
Externí odkaz:
https://doaj.org/article/0c0bf41846834c7fb06130e35d71184d
Autor:
Martin H. Prins, Anthonie W.A. Lensing, Paolo Prandoni, Philip S. Wells, Peter Verhamme, Jan Beyer-Westendorf, Rupert Bauersachs, Henri Bounameaux, Timothy A. Brighton, Alexander T. Cohen, Bruce L. Davidson, Hervé Decousus, Ajay K. Kakkar, Bonno van Bellen, Akos F. Pap, Martin Homering, Miriam Tamm, Jeffrey I. Weitz
Publikováno v:
Blood Advances, Vol 2, Iss 7, Pp 788-796 (2018)
Abstract: The optimal duration of anticoagulation for venous thromboembolism (VTE) is uncertain. In this prespecified analysis, we used data from 2 randomized trials, which compared once-daily rivaroxaban (20 mg or 10 mg) with aspirin (100 mg) or pla
Externí odkaz:
https://doaj.org/article/6e056cdc7a37471ba8ae950a01ffc81e